Susquehanna International Group’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$663K Buy
291,896
+263,162
+916% +$597K ﹤0.01% 3922
2025
Q1
$18.3K Sell
28,734
-31,044
-52% -$19.7K ﹤0.01% 6162
2024
Q4
$61.6K Buy
59,778
+49,474
+480% +$51K ﹤0.01% 5821
2024
Q3
$12.2K Sell
10,304
-15,615
-60% -$18.4K ﹤0.01% 5451
2024
Q2
$31.6K Sell
25,919
-910,859
-97% -$1.11M ﹤0.01% 5334
2024
Q1
$2.04M Buy
936,778
+897,786
+2,302% +$1.96M ﹤0.01% 1799
2023
Q4
$60.4K Sell
38,992
-49,578
-56% -$76.8K ﹤0.01% 5508
2023
Q3
$114K Sell
88,570
-1,672
-2% -$2.16K ﹤0.01% 4865
2023
Q2
$155K Sell
90,242
-257,544
-74% -$443K ﹤0.01% 4787
2023
Q1
$525K Buy
347,786
+334,618
+2,541% +$505K ﹤0.01% 3748
2022
Q4
$21.1K Sell
13,168
-82
-0.6% -$131 ﹤0.01% 5356
2022
Q3
$19K Sell
13,250
-23,475
-64% -$33.7K ﹤0.01% 5720
2022
Q2
$67K Sell
36,725
-45,076
-55% -$82.2K ﹤0.01% 5160
2022
Q1
$218K Sell
81,801
-44,902
-35% -$120K ﹤0.01% 4714
2021
Q4
$549K Buy
126,703
+5,017
+4% +$21.7K ﹤0.01% 3658
2021
Q3
$620K Buy
121,686
+12,420
+11% +$63.3K ﹤0.01% 3406
2021
Q2
$692K Sell
109,266
-18,192
-14% -$115K ﹤0.01% 3484
2021
Q1
$985K Buy
127,458
+113,099
+788% +$874K ﹤0.01% 3021
2020
Q4
$94K Sell
14,359
-9,465
-40% -$62K ﹤0.01% 4508
2020
Q3
$158K Sell
23,824
-2,747
-10% -$18.2K ﹤0.01% 3974
2020
Q2
$221K Buy
26,571
+6,719
+34% +$55.9K ﹤0.01% 3627
2020
Q1
$152K Buy
19,852
+4,234
+27% +$32.4K ﹤0.01% 3913
2019
Q4
$130K Sell
15,618
-13,297
-46% -$111K ﹤0.01% 3623
2019
Q3
$213K Sell
28,915
-18,544
-39% -$137K ﹤0.01% 3791
2019
Q2
$532K Buy
+47,459
New +$532K ﹤0.01% 2845
2019
Q1
Hold
0
3288
2018
Q4
Hold
0
3855
2018
Q3
Hold
0
3569
2018
Q2
Hold
0
3809
2017
Q1
Sell
-33,186
Closed -$365K 3450
2016
Q4
$365K Buy
+33,186
New +$365K ﹤0.01% 3252
2016
Q1
Sell
-23,222
Closed -$485K 3929
2015
Q4
$485K Buy
+23,222
New +$485K ﹤0.01% 3008